Outpatient Therapies Physicians Special Programs Patient Conditions Rehabilitation Orthopaedics

 
 

Kernan Hospital

Home > Medical Reference > Encyclopedia (Spanish)

Toggle: English / Spanish

Ask Our Experts

Get answers to your specific medical questions from Kernan Hospital experts.

Note: This is for informational purposes only. Doctors cannot provide a diagnosis via e-mail.

 

Related Content

Kernan Hospital

Our Services

Patient Success Stories

Our Doctors

Hepatitis C - Información general

Nombres alternativos

Hepatitis no A o no B

Definición:

Es una enfermedad viral que lleva a hinchazón (inflamación) del hígado.

Causas, incidencia y factores de riesgo:

La infección de hepatitis C es causada por el virus de la hepatitis C (VHC) y las personas que pueden estar en riesgo de padecerla son aquellas que:

  • Han estado sometidas a diálisis renal durante mucho tiempo
  • Tienen contacto frecuente con sangre en su trabajo (por ejemplo, los trabajadores del campo de la salud)
  • Tienen relaciones sexuales con una persona con hepatitis C
  • Se inyectan drogas alucinógenas o comparten agujas con alguien que tiene hepatitis C
  • Recibieron una transfusión de sangre antes de julio de 1992
  • Recibieron sangre, hemoderivados u órganos sólidos de un donante que tiene hepatitis C
  • Comparten elementos de uso personal, como cepillos de dientes o máquinas de afeitar, con alguien que tiene hepatitis C
  • Nacieron de una madre infectada con hepatitis C

Otras infecciones por virus de la hepatitis abarcan hepatitis A y hepatitis B. Cada infección de hepatitis viral es causada por un virus diferente.

  • Fecha de revisión: 2/20/2008
  • Versión en inglés revisada por:Christian Stone, MD, Division of Gastroenterology, Washington University in St. Louis, School of Medicine, St. Louis, MO. Review provided by VeriMed Healthcare Network. Also reviewed by David Zieve, MD, MHA, Medical Director, A.D.A.M., Inc.
  • Traducción y localización realizada por: DrTango, Inc

Referencias

Shiffman ML, Suter F, Bacon BR, et al. Peginterferon alfa-2a and ribavirin for 16 or 24 weeks in HCV genotype 2 or 3. N Engl J Med. 2007;357:124-34.

Wong T. Hepatitis C: a review for primary care physicians. CMAJ. 2006;174:649-59.

Rocca LG. Management of patients with hepatitis C in a community setting: diagnosis, discussions and decisions to treat. Ann Fam Med. 2004; 2:116-124.

A.D.A.M., Inc. is accredited by URAC, also known as the American Accreditation HealthCare Commission (www.urac.org). URAC's accreditation program is the first of its kind, requiring compliance with 53 standards of quality and accountability, verified by independent audit. A.D.A.M. is among the first to achieve this important distinction for online health information and services. Learn more about A.D.A.M.'s editorial process. A.D.A.M. is also a founding member of Hi-Ethics (www.hiethics.com) and subscribes to the principles of the Health on the Net Foundation (www.hon.ch).

The information provided herein should not be used during any medical emergency or for the diagnosis or treatment of any medical condition. A licensed physician should be consulted for diagnosis and treatment of any and all medical conditions. Call 911 for all medical emergencies. Links to other sites are provided for information only -- they do not constitute endorsements of those other sites. Copyright 1997-2007 A.D.A.M., Inc. Any duplication or distribution of the information contained herein is strictly prohibited.

adam.com
Physicians Special Programs Patient Conditions Physical Therapy